MINK1 silencing resulted in decreased motility and proliferation of breast cancer and CRC cells, as well as reduced viability of OSCC cells [24,43,162], it can thus be involved in the metastatic spread of cancer cells and its targeting may be a good treatment strategy for several types of cancer. This evidence concerns the gene MINK1 and breast cancer.